Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products
Wolfhart Kreuz1
, Carmen Escuriola Ettingshausen1
, Alex Zyschka1
, Johannes Oldenburg2
, Inmaculada Martinez Saguer1
, Silke Ehrenforth1
, Thomas Klingebiel1
1The Centre of Pediatrics III, Department of Hematology and Oncology, Comprehensive Care Centre of Thrombosis and Haemostasis, Johann-Wolfgang-Goethe-University Hospital, Frankfurt am Main and the Institute of Human Genetics (J. Oldenburg) University, Würzburg, Germany
2German Red Cross Blood Bank, Frankfurt Am Main, Germany